RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
6.44
-0.30 (-4.45%)
At close: Mar 20, 2026, 4:00 PM EDT
6.44
0.00 (0.00%)
After-hours: Mar 20, 2026, 6:03 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $265.76 million as of March 20, 2026. Its market cap has decreased by -75.32% in one year.
Market Cap
265.76M
Enterprise Value
48.25M
1-Year Change
-75.32%
Ranking
Category
Stock Price
$6.44
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $265.76M, a decrease of -37.37%. That is a compound annual growth rate of -9.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 278.14M | -35.08% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacific Biosciences of California | 399.49M |
| Standard BioTools | 376.42M |
| Viemed Healthcare | 359.78M |
| Cerus | 345.91M |
| Delcath Systems | 325.92M |
| ClearPoint Neuro | 284.92M |
| Senseonics Holdings | 264.82M |
| CapsoVision | 255.76M |